| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +0.00% | +3.94% | +1.30% | +2.64% | +2.64% | — |
| 14d | 1 | +0.00% | +6.25% | +2.49% | +3.76% | +3.76% | — |
| 30d | 1 | +0.00% | +1.56% | +4.59% | -3.03% | -3.03% | — |
| 60d | 1 | +0.00% | +15.15% | +8.13% | +7.03% | +7.03% | — |
| 90d | 1 | +100.00% | -3.85% | +9.16% | -13.01% | -13.01% | — |
| 180d | 1 | +100.00% | -17.11% | +17.24% | -34.35% | -34.35% | — |
| 1y | 1 | +100.00% | -39.48% | +28.86% | -68.34% | -68.34% | — |
| 2y | 1 | +100.00% | -78.60% | +12.75% | -91.35% | -91.35% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED |
|---|---|---|---|---|---|---|---|
| NEO NEOGENOMICS INC | SALE Chief Medical Officer | 6,667 | — | — | 0 | Apr 22, 2021 | Apr 26, 2021 ↗ |
| NEO NEOGENOMICS INC | PURCHASE Chief Medical Officer | 9,378 | $28.33 | $265.7K | 130,847 | Apr 22, 2021 | Apr 26, 2021 ↗ |
| NEO NEOGENOMICS INC | PURCHASE Chief Medical Officer | 9,005 | $19.60 | $176.5K | 121,469 | Apr 22, 2021 | Apr 26, 2021 ↗ |
| NEO NEOGENOMICS INC | SALE Chief Medical Officer | 9,005 | — | — | 18,012 | Apr 22, 2021 | Apr 26, 2021 ↗ |
| NEO NEOGENOMICS INC | SALE Chief Medical Officer | 9,378 | — | — | 28,136 | Apr 22, 2021 | Apr 26, 2021 ↗ |
| NEO NEOGENOMICS INC | PURCHASE Chief Medical Officer | 6,667 | $9.22 | $61.5K | 112,464 | Apr 22, 2021 | Apr 26, 2021 ↗ |
| NEO NEOGENOMICS INC | PURCHASEGRANT Stock grant | 29,895 | $53.17 | $1.59M | 29,895 | Mar 2, 2021 | Mar 3, 2021 ↗ |
| NEO NEOGENOMICS INC | PURCHASEGRANT Stock grant | 5,276 | — | — | 105,797 | Mar 2, 2021 | Mar 3, 2021 ↗ |
| NEO NEOGENOMICS INC | PURCHASE Chief Medical Officer | 20,000 | $7.27 | $145.4K | 81,717 | Dec 14, 2020 | Dec 15, 2020 ↗ |
| NEO NEOGENOMICS INC | SALE Chief Medical Officer | 20,000 | — | — | 0 | Dec 14, 2020 | Dec 15, 2020 ↗ |
| NEO NEOGENOMICS INC | SALE Chief Medical Officer | 9,005 | — | — | 27,017 | Dec 14, 2020 | Dec 15, 2020 ↗ |
| NEO NEOGENOMICS INC | SALE Chief Medical Officer | 50,000 | — | — | 0 | Dec 14, 2020 | Dec 15, 2020 ↗ |
| NEO NEOGENOMICS INC | PURCHASE Chief Medical Officer | 50,000 | $6.98 | $349.0K | 61,717 | Dec 14, 2020 | Dec 15, 2020 ↗ |
| NEO NEOGENOMICS INC | SALE Chief Medical Officer | 16,666 | — | — | 8,334 | Dec 14, 2020 | Dec 15, 2020 ↗ |
| NEO NEOGENOMICS INC | PURCHASE Chief Medical Officer | 9,005 | $19.60 | $176.5K | 120,721 | Dec 14, 2020 | Dec 15, 2020 ↗ |
| NEO NEOGENOMICS INC | SALE Chief Medical Officer | 20,200 | $51.06 | $1.03M | 100,521 | Dec 14, 2020 | Dec 15, 2020 ↗ |
| NEO NEOGENOMICS INC | SALE Chief Medical Officer | 13,333 | — | — | 6,667 | Dec 14, 2020 | Dec 15, 2020 ↗ |
| NEO NEOGENOMICS INC | PURCHASE Chief Medical Officer | 16,666 | $13.87 | $231.2K | 111,716 | Dec 14, 2020 | Dec 15, 2020 ↗ |
| NEO NEOGENOMICS INC | PURCHASE Chief Medical Officer | 13,333 | $9.22 | $122.9K | 95,050 | Dec 14, 2020 | Dec 15, 2020 ↗ |
| NEO NEOGENOMICS INC | PURCHASEGRANT Stock grant | 37,514 | $28.33 | $1.06M | 37,514 | Mar 2, 2020 | Mar 3, 2020 ↗ |
| NEO NEOGENOMICS INC | PURCHASEGRANT Stock grant | 5,824 | — | — | 11,717 | Mar 2, 2020 | Mar 3, 2020 ↗ |